Patient Care and General Interest A new study looking a dietary protein sources and LDL cholesterol levels calls into question the idea that white meat is more heart healthy than red meat.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Heart Failure - Ischemic
In Global News: Recommendation to Reclassify Surgical Staplers, Defining Cardiogenic Shock, and Weighing In on E-Cigarettes
June 7, 2019
May 29, 2019
In this Giants of Cardiothoracic Surgery interview, Marco Nardini speaks with Antonio Maria Calafiore of the Prince Sultan Cardiac Center in Riyadh, Saudi Arabia.
In Global News: Cardiac Regeneration in Pigs, Health Effects of Marijuana Use, and Running to Reduce Aortic Stiffness
May 10, 2019
Patient Care and General Interest
Impact of Cell Therapy on Cardiovascular Outcomes in Patients With Refractory Angina: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
April 1, 2019
A robust meta-analysis of randomized controlled trials on stem cell therapies for refractory angina, offering some encouragement.
March 26, 2019
The investigators published the final analysis of the MOMENTUM 3 trial comparing the fully magnetically levitated centrifugal continuous-flow HeartMate 3 pump to the mechanical-bearing axial continuous-flow HeartMate II pump.
March 4, 2019
An important review in a mainstream periodical read by cardiologist colleagues.
The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships
February 7, 2019
In the February issue of The Annals, The Society of Thoracic Surgeons published the first annual report after the Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs) joined the STS National Database in January 2018. This report summarizes the outcomes in patients (≥19 years of age) undergoing durable MCS implant b
February 5, 2019
In a letter to healthcare providers, the US FDA summarized a recent evaluation of a postapproval study of the Abiomed Impella RP system. In clinical trials, 73% of patients survived 30 days after device explant, hospital discharge, or to definitive intervention. In the postapproval study, just over 17% of patients met this goal.
Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry
January 30, 2019
Garbade and colleagues compared outcomes reported during the European Conformity (CE) Mark clinical trial of the HeartMate 3 left ventricular assist device (LVAD) to outcomes for patients treated since the device came to market.
December 26, 2018
A randomized controlled trial coauthored by the Editor-in-Chief of the host periodical on the risk management of multivessel diabetic coronopathy.